Literature DB >> 10462066

Effects of cannabinoids on energy metabolism.

M Guzmán1, C Sánchez.   

Abstract

The present review summarizes the recent work carried out by our group on the link between signal transduction pathways and metabolic regulation systems as affected by cannabinoids. In cells such as astrocytes and lymphocytes, which express cannabinoid receptors, physiologically relevant doses of cannabinoids induce a remarkable metabolic stimulation as determined e.g. by enhanced glucose utilization. Studies performed in astrocytes show that the cannabinoid-evoked stimulation of glucose metabolism is independent of adenylyl cyclase inhibition, and seems to rely on the cascade CB1 cannabinoid receptor --> Sphingomyelin breakdown --> Ceramide --> Raf-1 --> Mitogen-activated protein kinase (MAPK) --> Glucose utilization. A role for phosphoinositide 3'-kinase in the stimulation of glucose utilization by cannabinoids is also put forward. In addition, ceramide generated upon CB1 cannabinoid receptor activation may enhance ketone body production by astrocytes independently of MAPK. Anandamide has also been shown to exert metabolic effects in hepatocytes, cells that do not express cannabinoid receptors. The biological role of cannabinoids as modulators of metabolism is as yet unclear.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462066     DOI: 10.1016/s0024-3205(99)00288-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus.

Authors:  J J Rodriguez; K Mackie; V M Pickel
Journal:  J Neurosci       Date:  2001-02-01       Impact factor: 6.167

Review 2.  Cannabinoids and neuroprotection in basal ganglia disorders.

Authors:  Onintza Sagredo; Moisés García-Arencibia; Eva de Lago; Simone Finetti; Alessandra Decio; Javier Fernández-Ruiz
Journal:  Mol Neurobiol       Date:  2007-06-23       Impact factor: 5.590

Review 3.  Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets.

Authors:  Srikrishnan Mallipeddi; David R Janero; Nikolai Zvonok; Alexandros Makriyannis
Journal:  Biochem Pharmacol       Date:  2016-11-24       Impact factor: 5.858

4.  Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation.

Authors:  Kwang H Ahn; Mariam M Mahmoud; Debra A Kendall
Journal:  J Biol Chem       Date:  2012-02-16       Impact factor: 5.157

Review 5.  Prospects for cannabinoid therapies in basal ganglia disorders.

Authors:  Javier Fernández-Ruiz; Miguel Moreno-Martet; Carmen Rodríguez-Cueto; Cristina Palomo-Garo; María Gómez-Cañas; Sara Valdeolivas; Carmen Guaza; Julián Romero; Manuel Guzmán; Raphael Mechoulam; José A Ramos
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

Review 6.  CB(1) cannabinoid receptors and their associated proteins.

Authors:  Allyn C Howlett; Lawrence C Blume; George D Dalton
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

7.  CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes.

Authors:  Paola Nieri; Rosamiria Greco; Barbara Adinolfi; Maria Cristina Breschi; Enrica Martinotti; Carla Nannetti; Adriano Podestà
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-18       Impact factor: 3.000

Review 8.  The endocannabinoid signaling system: a potential target for next-generation therapeutics for alcoholism.

Authors:  Balapal S Basavarajappa
Journal:  Mini Rev Med Chem       Date:  2007-08       Impact factor: 3.862

9.  Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels.

Authors:  Joseph N Brown; Gabriel M Ortiz; Thomas E Angel; Jon M Jacobs; Marina Gritsenko; Eric Y Chan; David E Purdy; Robert D Murnane; Kay Larsen; Robert E Palermo; Anil K Shukla; Theresa R Clauss; Michael G Katze; Joseph M McCune; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2012-05-11       Impact factor: 5.911

10.  Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.

Authors:  Balapal S Basavarajappa
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.